Open Targets Blog
  • Home
  • Science
  • Q&A
  • Release Notes
  • Outreach
Subscribe

Open Targets

A collection of 23 posts

Open Targets

Looking for cell line models to predict drug response in cancer patients?

On this World Cancer Day, Hanna writes about Cellector, an open source tool for the selection of clinically relevant cancer cell lines for in vitro experiments.

Hanna Najgebauer Hanna Najgebauer
Open Targets Platform

From antibody to zinc finger: an A-Z of Open Targets

As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. It's D-time.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets Platform

From antibody to zinc finger: an A-Z of Open Targets

As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. Third in the series is C.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

From antibody to zinc finger: an A-Z of Open Targets

As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. Second in the series is B.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
release notes

Open Targets Platform: what's new in our latest release

Our latest release of the Open Targets Platform is out. More targets, more evidence, more target-disease associations and a new prioritisation view.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

From antibody to zinc finger: an A-Z of Open Targets

As users discover our freely available resources, it’s time to take a closer look at the lexicon of terms that matter to Open Targets. First in the series is A.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets Platform

We have a new release of the Open Targets Platform

The latest version of the Open Targets Platform is out. Why not check the new target-disease associations and the new chemical probes we have to offer?

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets Platform

Everything you need to know about the new GWAS Catalog

Open Targets is investing in a new project to expand the scope of the GWAS Catalog to include targeted arrays, such as MetaboChip and ImmunoChip.

Annalisa Buniello Annalisa Buniello
Europe PMC

How Europe PMC can help you find associations between genes and diseases

Open Targets Q&A on how you can stay up-to-date with the latest advances in drug discovery.

Maria Levchenko
release notes

The latest release of the Open Targets Platform is out!

We have a new release of the Open Targets Platform. New data source for target-disease associations, new drug visualisations, cancer biomarkers, and more.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

Touring with Takeda

Following Takeda joining Open Targets in December 2017, I set off to Takeda in the US and Japan for a series of workshops.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

Open Targets Platform: we have a new release

The latest release of Open Targets Platform is out. We now have the cancer hallmarks, targeted association studies, a YouTube channel and much more.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

How to predict the success of drug development

If you are attending BioData World West 2018 in San Francisco, come one day earlier and join our training sessions, a workshop and a datathon.

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

How CRISPR will guide the way to better cancer therapies

Fiona Behan tells us why she works in cancer research with Open Targets and how CRISPR/Cas9 has revolutionised the fight against cancer.

Fiona Behan Fiona Behan
LINK

Introducing LINK: the Open Targets Literature Knowledge Graph

Explore half a billion relations between genes, diseases, drugs and key concepts extracted from PubMed abstracts using NLP (Natural Language Processing).

Andrea Pierleoni
Open Targets

Translation, Translation, Translation

Over the last 14 days, we have had two scientific meetings taking place right here on the Wellcome Genome Campus, the Translational Bioinformatics conference and the Translational Target Validation symposium. What did they

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
targetvalidation.org

Direct versus indirect evidence: should you care?

The latest release of our Open Targets Platform contains 5.1 million pieces of evidence for target-disease associations. Where does this evidence come from? How do we integrate the different evidence types? Our

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

Open Targets - First Impressions

I recently joined the Open Targets Consortium as Operations Director. This moved me from almost the very end of the R&D pipeline where I had been working on processes for small

David Hulcoop David Hulcoop
targetvalidation.org

What do we have in store for you in the run up to Christmas?

The latest release of our Open Targets Platform is out. We have plenty of new web features and new data to help your journey into drug discovery. These are our latest stats: 31,

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
targetvalidation.org

An approach to visualising pathway evidence

The starting point in drug discovery is often a specific target or disease. But what if instead you have a specific pathway to start with? As part of an Open Targets research project

Aidan MacNamara
targetvalidation.org

Did you see the latest version of Open Targets Platform?

That's right. The Open Targets Platform v1.2 is out! In this release, we have new web displays and plenty of extra data to assist you in drug discovery and validation: 30,591

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
Open Targets

Outreach in Open Targets: supercharge your target identification skills

What is it? Outreach, you may have heard the word before. But what is it, really? According to the Cambridge Dictionary, outreach is an effort to bring services or information to people where

Dr Denise Carvalho-Silva Dr Denise Carvalho-Silva
api

Open Targets API Tutorial: Getting Started

Please note we have changed the base URL of our REST API. It is now https://api.opentargets.io/v3/platform. If you are looking for our stats, you will use https://api.

Eliseo Papa Eliseo Papa
Open Targets Blog © 2019
Latest Posts Twitter Ghost
Open Targets Blog

Subscribe to Open Targets Blog

Stay up to date! Get all the latest & greatest posts delivered straight to your inbox